1  pathway is one of the targets of first-line antituberculous drugs.

2 cular testing does not yield results for all antituberculous drugs.

3 n cases) had isolates resistant to 1 or more antituberculous drugs, and 3 (19% of all Tibetan cases)

4 ive animals, allowing accurate evaluation of antituberculous drug efficacy.

5 ared genes included target genes of existing antituberculous drugs including SQ109, which targets the

6 traditional view that acquired resistance to antituberculous drugs is driven by poor compliance and p

7 erculosis gene expression in response to the antituberculous drug isoniazid.

8 e-bound structure, we suggest a new class of antituberculous drugs, made by connecting two trehalose

9 osynthetic pathway is a well known source of antituberculous drug targets.

10    Given the low potency of many second-line antituberculous drugs, we hypothesized that an aggressiv